2023 annual financial data
Barinthus Biotherapeutics 2023 Operating margin
Barinthus Biotherapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -10,463.09%.
Operating income was -83,914,000 USD and net income was -73,347,000 USD.
Operating cash flow was -50,925,000 USD.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 802,000 USD
- Operating income
- -83,914,000 USD
- Net income
- -73,347,000 USD
- Operating cash flow
- -50,925,000 USD